Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca to present new data demonstrating breadth of research portfolio in renal disease at ASN Kidney Week 2018
-
SOLO-1 Phase III trial demonstrates Lynparza maintenance therapy cut risk of disease progression or death by 70% in patients with newly-diagnosed, advanced BRCA-mutated ovarian cancer
-
New data on mechanisms of acquired resistance after 1st-line Tagrisso in NSCLC support initiation of ORCHARD trial to explore post-progression treatment options
-
CHMP issues a positive opinion for Bevespi Aerosphere for the treatment of chronic obstructive pulmonary disease
-
US FDA grants Lynparza Orphan Drug Designation for pancreatic cancer
-
AstraZeneca presents advances in improving treatment options for ovarian and lung cancer patients at ESMO 2018 Congress
-
Imfinzi is the first immunotherapy to demonstrate significant overall survival benefit in unresectable, Stage III lung cancer
-
Bydureon receives positive EU CHMP opinion for EXSCEL cardiovascular outcomes data
-
European Commission approves Imfinzi for locally-advanced, unresectable NSCLC
-
Farxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000 patients with type-2 diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
